Moreover, EGFR-mutant LUAD typically exhibits a “cold” immune phenotype and shows limited response to immune checkpoint inhibitors (ICIs), suggesting that this subtype possesses distinct features in terms of tumor microenvironment (TME), immune escape mechanisms, and gene expression profiles (8, 9). The gene discussed is EGFR; the disease is neoplasm.